Therapies for hematologic malignancies
US9238070B2 · kind B2 · utility
2Cited by
55References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2013 |
| Grant date | Jan 19, 2016 |
| Priority date | — |
| Expiry date | Aug 21, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods that relate to a novel therapeutic strategy for the treatment of hematological malignancies and inflammatory diseases. In particular, the method comprises administration of a compound of formula A,
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.